Detalhe da pesquisa
1.
Human Genetic Determinants of Viral Diseases.
Annu Rev Genet
; 51: 241-263, 2017 11 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-28853921
2.
An HTLV-1 envelope mRNA vaccine is immunogenic and protective in New Zealand rabbits.
J Virol
; 98(2): e0162323, 2024 Feb 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38193692
3.
HBZ upregulates myoferlin expression to facilitate HTLV-1 infection.
PLoS Pathog
; 19(2): e1011202, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36827461
4.
HTLV-1 Hbz protein, but not hbz mRNA secondary structure, is critical for viral persistence and disease development.
PLoS Pathog
; 19(6): e1011459, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-37327244
5.
The Pleiotropic Effects of YBX1 on HTLV-1 Transcription.
Int J Mol Sci
; 24(17)2023 Aug 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-37685922
6.
HTLV-1 CTCF-binding site is dispensable for in vitro immortalization and persistent infection in vivo.
Retrovirology
; 16(1): 44, 2019 12 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-31864373
7.
PRMT5-Selective Inhibitors Suppress Inflammatory T Cell Responses and Experimental Autoimmune Encephalomyelitis.
J Immunol
; 198(4): 1439-1451, 2017 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28087667
8.
Functional Comparison of HBZ and the Related APH-2 Protein Provides Insight into Human T-Cell Leukemia Virus Type 1 Pathogenesis.
J Virol
; 90(7): 3760-72, 2016 Jan 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-26819304
9.
The B-cell-specific transcription factor and master regulator Pax5 promotes Epstein-Barr virus latency by negatively regulating the viral immediate early protein BZLF1.
J Virol
; 87(14): 8053-63, 2013 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-23678172
10.
Viral genome methylation differentially affects the ability of BZLF1 versus BRLF1 to activate Epstein-Barr virus lytic gene expression and viral replication.
J Virol
; 87(2): 935-50, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23135711
11.
Correction: PRMT5-Selective Inhibitors Suppress Inflammatory T Cell Responses and Experimental Autoimmune Encephalomyelitis.
J Immunol
; 199(8): 3004, 2017 10 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29018151
12.
HTLV-1 infected T cells cause bone loss via small extracellular vesicles.
bioRxiv
; 2024 Mar 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38496506
13.
Upregulation of Neuropilin-1 Inhibits HTLV-1 Infection.
Pathogens
; 12(6)2023 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37375521
14.
The PRMT5 inhibitor EPZ015666 is effective against HTLV-1-transformed T-cell lines in vitro and in vivo.
Front Microbiol
; 14: 1101544, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36819050
15.
Retroviral b-Zip protein (HBZ) contributes to the release of soluble and exosomal immune checkpoint molecules in the context of neuroinflammation.
J Extracell Biol
; 2(7)2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37547182
16.
Human T-Cell Leukemia Virus Type 1 Envelope Protein: Post-Entry Roles in Viral Pathogenesis.
Viruses
; 14(1)2022 01 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-35062342
17.
Regulation of HTLV-1 transformation.
Biosci Rep
; 42(3)2022 03 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-35169839
18.
Novel perspectives on antisense transcription in HIV-1, HTLV-1, and HTLV-2.
Front Microbiol
; 13: 1042761, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36620051
19.
The Past, Present, and Future of a Human T-Cell Leukemia Virus Type 1 Vaccine.
Front Microbiol
; 13: 897346, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35602078
20.
HTLV-1 intragenic viral enhancer influences immortalization phenotype in vitro, but is dispensable for persistence and disease development in animal models.
Front Immunol
; 13: 954077, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35958554